Ali Behbahani - 19 Jun 2026 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Reporting relationship: Director
Issuer ticker: BDTX
Reported as of: 19 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 16:19:12 UTC
Prior SEC filing: 12 Jun 2026
Next SEC filing: 29 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Zachary Bambach, attorney-in-fact

Key filing fact

Ali Behbahani filed Form 4 for Black Diamond Therapeutics, Inc. (BDTX) on 22 Jun 2026.

Key facts

This page summarizes Ali Behbahani's Form 4 filing for Black Diamond Therapeutics, Inc. (BDTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 16:19.

Change

Previous filing in this sequence was filed on 12 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001613867 Primary reporting owner

Behbahani Ali

Relationship: Director
Address: 2855 SAND HILL RD, MENLO PARK
Signature: /s/ Zachary Bambach, attorney-in-fact
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDTX transaction

Common Stock

Award

Transaction value
Shares: +8,961
Change %: +9.6%
Price: $1.66^*
Shares after: 102,529
Date: 19 Jun 2026
Ownership: Direct
Footnotes: F1, F2

BDTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,448,757
Date: 19 Jun 2026
Ownership: See Note 3
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares were issued in accordance with the Issuer's Sixth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.

Footnote F2

The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 18, 2026.

Footnote F3

The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.